 1. Patients on diet therapy and exercise therapy for 3 to 6 months prior to the start of screening, with baseline fasting plasma glucose 126 mgdL and 2-hour plasma glucose of 140 to 199 mgdL revised WHO criteria during a 75 g oral glucose tolerance test OGTT in the screening period 